Michael S. Diamond, MD, PhD is the Herbert S. Gasser Professor of Medicine at Washington University. He is recognized internationally for his work involving Zika, West Nile, chikungunya, and related emerging viruses. This past summer he developed a mouse model of SARS-CoV-2, which facilitated the development of a nasal vaccine that prevented infection in mice. Diamond and his team also recently identified new receptors for multiple alphaviruses, and has translated these discoveries into soluble receptor decoy molecules with therapeutic potential molecule. Dr. Diamond is an elected member of the American Society of Clinical Investigation, the American Association for the Advancement of Science, the Association of American Physicians, and the National Academy of Medicine. He is also currently a member of the Scientific Advisory Board of the Investigators in the Pathogenesis of Infectious Disease program at the Burroughs Wellcome Fund and an elected Councilor for the Association of American Physicians.
« Go Back